IRCT20190423043361N1已完成4 期
The effect of montelukast on the serum levels of inflammatory factors in patients with chronic obstructive pulmonary disease (COPD) in intervention and control groups
Khoram-Abad University of Medical Sciences0 个研究点目标入组 74 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 74
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 40 years 至 70 years（—）
- 性别
- All
入选标准
- •COPD patients
- •aged 40 to 70 years
- •Patients with stable conditions in the last trimester
- •Patients who are at stages II-III-IV of the disease
排除标准
- •History of hospitalization
- •History of long-term Corticosteroid use
- •Other inflammatory diseases such as cardiovascular, rheumatic, pulmonary, and liver disease
研究者
相似试验
招募中
3 期
The effect of Montelukast on COVID 19 disease activityIRCT20181208041886N3Abidi Pharmaceutical company60
进行中（未招募）
不适用
Effect of montelukast on levels of metalloproteinase-9 (MMP-9), MMP-12, tissue inhibitor metalloproteinase-1 (TIMP-1), procollagen peptide type 1 C-terminal (PICP) and TGF-beta1 on induced sputum of children suffering from intermittent asthma. - NDIntermittent asthmaMedDRA version: 9.1Level: LLTClassification code 10003553Term: AsthmaEUCTR2008-006373-33-ITAZIENDA OSPEDALIERA ISTITUTI OSPITALIERI DI VERONA
招募中
2 期
Evaluation of the effect of Montelukast in allergic rhinitis, Evaluation of the effect of neotadine in the treatment of allergic rhinitisIRCT20211205053277N1Tehran University of Medical Sciences60
尚未招募
3 期
The effect of Montelukast in the treatment of cystitisCystitisCystitis.IRCT20220203053919N1Arak University of Medical Sciences56
已完成
3 期
Therapeutic effect of Montelukast in patients with oral lichen planusLichen Planusichen Planus.IRCT2012110811389N2Vice Chancellor for Research , Hamedan University of Medical Sciences200